Abstract
As shown in many reports, allogeneic BMT can help cure autoimmune diseases. Conversely, we present a 24-year-old woman with Graves' disease, which was diagnosed just before BMT for CML. The Graves' disease remitted immediately after BMT but relapsed 18 months later. Since the donor was free from thyroid diseases and the patient showed a rapid shift to complete donor chimerism after BMT, the autoimmune problem seemed neither to arise directly from the donor nor simply from the recipient's residual lymphocytes. On the contrary, it was most likely compounded by chronic GVHD as suggested by the accompanying GVHD symptoms and the absolute donor karyotype in bone marrow cells. A Graves' disease-susceptible HLA allele was also shared between recipient and donor, possibly enhancing the chances of this condition developing. Thus, allogeneic BMT may facilitate relapses in autoimmune diseases as well as alleviating them.
Bone Marrow Transplantation (2001) 28, 1151–1153.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ikehara S, Yasumizu R, Inaba M et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation Proc Natl Acad Sci USA 1989 86: 3306–3310
Snowden JA, Kearney P, Kearney A et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation Arthritis Rheum 1998 41: 453–459
Sherer Y, Shoenfeld Y . Autoimmune diseases and autoimmunity post-bone marrow transplantation Bone Marrow Transplant 1998 22: 873–881
Karthaus M, Gabrysiak T, Brabant G et al. Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells Bone Marrow Transplant 1997 20: 697–699
Takeshita A, Shinjo K, Ohno R . Graves' disease after bone marrow transplantation (letter) Ann Intern Med 1999 131: 157
Berisso GA, van Lint MT, Bacigalupo A, Marmont AM . Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease Bone Marrow Transplant 1999 23: 1091–1092
Mckendry RJR, Huebsch L, Leclair B . Progression of rheumatoid arthritis following bone marrow transplantation: a case report with a 13-year follow up Arthritis Rheum 1996 39: 1246–1253
Lum LG . The kinetics of immune reconstitution after human marrow transplantation Blood 1987 69: 369–380
Parkman R, Weinberg KI . Immunological reconstitution following bone marrow transplantation Immunol Rev 1997 157: 73–78
Oliveira JSR, Bahia D, Franco M et al. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal Bone Marrow Transplant 1999 23: 99–101
Moller E, Bohme J, Valugerdi MA et al. Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of ‘autoreactive’ T lymphocytes Immunol Rev 1990 118: 5–19
Rayner DC, Champion BR . Thyroid Autoimmunity RG Landes Company: Austin 1995 pp 91–103
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hsiao, LT., Liu, JH., Yen, CC. et al. Relapse of Graves' disease after successful allogeneic bone marrow transplantation. Bone Marrow Transplant 28, 1151–1153 (2001). https://doi.org/10.1038/sj.bmt.1703291
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703291
Keywords
This article is cited by
-
Alemtuzumab Therapy for Multiple Sclerosis
Neurotherapeutics (2013)
-
Alemtuzumab: eine weitere Chance zur Therapie der Multiplen Sklerose
Der Nervenarzt (2012)
-
Alemtuzumab als neue Therapieoption der Multiplen Sklerose
Der Nervenarzt (2009)
-
Donor origin of Graves disease in a BMT recipient: evidence from FISH studies of thyroid tissue
Bone Marrow Transplantation (2006)
-
Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation
Bone Marrow Transplantation (2005)